0000899243-22-004834.txt : 20220204
0000899243-22-004834.hdr.sgml : 20220204
20220204163513
ACCESSION NUMBER: 0000899243-22-004834
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220107
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doebele Robert
CENTRAL INDEX KEY: 0001856681
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40356
FILM NUMBER: 22593976
MAIL ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rain Therapeutics Inc.
CENTRAL INDEX KEY: 0001724979
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821130967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: (510) 953-5559
MAIL ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-07
0
0001724979
Rain Therapeutics Inc.
RAIN
0001856681
Doebele Robert
C/O RAIN THERAPEUTICS INC.
8000 JARVIS AVENUE, SUITE 204
NEWARK
CA
94560
0
1
0
0
EVP, Chief Scientific Officer
Stock Option (Right to Buy)
12.01
2022-01-07
4
A
0
72000
0.00
A
2032-01-07
Common Stock
72000
72000
D
This option represents a right to purchase a total of 72,000 shares of the Issuer's common stock, one quarter of which will vest on January 7, 2023, with the remaining three quarters vesting in equal monthly installments through January 7, 2026, subject to the Reporting Person's continued service to the Issuer.
/s/ Nelson Cabatuan, Attorney-in-fact for Robert Doebele
2022-02-04